Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control

V Thornton, D Lennon, K Rasanathan, J O'Hallahan, P Oster, J Stewart, S Tilman, I Aaberge, B Feiring, H Nokleby, E Rosenqvist, Karen White, S Reid, Edward (Kim) MULHOLLAND, M Wakefield, D Martin

    Research output: Contribution to journalArticle

    Original languageEnglish
    Pages (from-to)1395-1400
    Number of pages6
    JournalVaccine
    Volume24
    Issue number9
    Publication statusPublished - 2006

    Cite this

    Thornton, V., Lennon, D., Rasanathan, K., O'Hallahan, J., Oster, P., Stewart, J., Tilman, S., Aaberge, I., Feiring, B., Nokleby, H., Rosenqvist, E., White, K., Reid, S., MULHOLLAND, E. K., Wakefield, M., & Martin, D. (2006). Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control. Vaccine, 24(9), 1395-1400.